Glioblastoma (GBM) is the most prevalent and deadly primary brain tumor type, with a
discouragingly low survival rate and few effective treatments. An important function of the …

This scoping review examines the use of CRISPR/Cas9 gene editing in glioblastoma (GBM),
a predominant and aggressive brain tumor. Categorizing gene targets into distinct groups …

Objectives: Identify the epidemiology and pathophysiology of glioblastoma multiforme.
Assess strategies for the clinical and radiological evaluation of glioblastoma multiforme …

Simple Summary Glioblastoma stands as the most aggressive form of adult brain cancer,
often resulting in a median survival of 14.6 months even following surgical intervention …

Background and Objectives: To investigate the role of augmented reality (AR) in skull base
(SB) neurosurgery. Materials and Methods: Utilizing PRISMA methodology, PubMed and …

Glioblastoma (GB) is a rare but extremely aggressive brain tumor that significantly impacts
patient outcomes, affecting both duration and quality of life. The protocol established by …

Simple Summary This study explores hypoxia-inducible factors (HIFs) in glioblastoma
development, progression, and treatment. Reviewing 104 relevant studies, it highlights …

Chemodynamic therapy (CDT) has shown promising antitumor effects in various malignant
tumors. However, its application for glioblastoma (GBM) is significantly hindered by the …

Malignant gliomas (MGs), including glioblastoma (GBM), are the most aggressive and
common forms of primary brain tumors in adults, presenting a significant challenge in neuro …

Glioma cancer is the primary cause of cancer-related fatalities globally for both men and
women. Traditional chemotherapy treatments for this condition frequently result in reduced …